(a) The Administrative Director may maintain and post on the DWC website a listing by National Drug Code, RxCUI (clinical drug concept unique identifier maintained by the National Library of Medicine), or other unique pharmaceutical identifier, of drug products that are embodied in the MTUS Drug List. If posted, the listing will be regularly updated to account for revisions to the MTUS Drug List and for changes in drug products that are marketed for outpatient use.

(b) For each active ingredient on the MTUS Drug List, the product listing shall include brand name and therapeutically equivalent generic versions of outpatient prescription drugs and non-prescription drug products. The listing shall include only drug products that can be self-administered by the patient. Injectable drug products must be packaged and identified for patient self-administration.

(c) The listing shall include combination drugs with multiple active ingredients only if the combination of active ingredients is listed on the MTUS Drug List.

(d) The listing may include, but is not limited to, the following data elements: